Hostname: page-component-7c8c6479df-ph5wq Total loading time: 0 Render date: 2024-03-29T05:46:28.733Z Has data issue: false hasContentIssue false

Conclusion: A New Technologic Synthesis: The Children's Vaccine Initiative

Published online by Cambridge University Press:  14 October 2009

Suryanarayan Ramachandran
Affiliation:
Department of Biotechnology, India
Philip K. Russell
Affiliation:
The Johns Hopkins University School of Public Health

Extract

If the visionary goals of the Children's Vaccine Initiative (CVI) are to be achieved, it will have to be an initiating, integrating, and propelling force in the development, manufacturing, and use of vaccines. Success in solving the major technological challenges may depend first on solving the problem of incorporating the major players into the CVI. Today's relationship between private vaccine manufacturers and publicsector purchasers must give way to a new era of cooperation and coordination.

Type
Special Section: Vaccines and Public Health: Assessing Technologies and Public Policies
Copyright
Copyright © Cambridge University Press 1994

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

1.Martínez-Palomo, A., López-Cervantes, M., & Freeman, P.The role of vaccine research and development in the development of middle-income countries. International Journal of Technology Assessment in Health Care, 1994, 10, 3038.CrossRefGoogle ScholarPubMed
2. Declaration of New York. September 10, 1990, New York, NY.Google Scholar
3.Lemon, S. M., Milstien, J. B.The thermostability of vaccines: Technologies for improving the thermal stability of oral poliovirus vaccine. International Journal oj'Technology Assessment in Health Care, 1994, 10, 177184.CrossRefGoogle Scholar